Related Experiment Videos

[Cholesterol embolism in the lower limbs]

J P Claudel1, J Ninet, B Coppéré

  • 1Service de soins intensifs cardiologiques, Hôpital cardiologique Louis-Pradel, Lyon.

La Revue Du Praticien
|January 1, 1995
PubMed

Insights

Cholesterol embolism from aortic atherosclerosis can cause serious systemic complications, ranging from blue toe syndrome to multiple organ failure. Diagnosis involves biopsy and fundoscopy, but optimal treatment requires further research.

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Vascular Surgery

Context:

  • Atheromatous aorta is a significant source of cholesterol micro-emboli.
  • Emboli dislodgement can be spontaneous or triggered by medical procedures and treatments.
  • Cholesterol embolism is a serious complication of aortic atherosclerosis.

Purpose:

  • To elucidate the clinical spectrum and diagnostic methods for cholesterol embolism.
  • To highlight the prognostic implications of cholesterol embolism.
  • To underscore the need for established treatment protocols.

Summary:

  • Cholesterol crystals from atheromatous aorta can form micro-emboli, leading to diverse clinical presentations from asymptomatic cases to multi-system failure.
  • Commonly associated with 'blue toe' syndrome and renal insufficiency, the condition signifies a poor prognosis.
  • Diagnosis is typically confirmed via skin or muscle biopsy and fundoscopic examination.

Impact:

  • Enhances understanding of cholesterol embolism's broad clinical impact.
  • Emphasizes the diagnostic challenges and prognostic severity.
  • Identifies a critical gap in established therapeutic strategies for this condition.

Related Concept Videos